Renovaskuläre Hypertonie

  • R. E. Sosa
  • E. D. VaughanJr.


Etwa 50 Millionen Amerikaner haben eine Hypertonie. Bei den meisten Patienten ist die Ursache unbekannt, man bezeichnet die Erkrankung deshalb als essentielle Hypertonie. Bei 5–15% der Patienten mit Hypertonie ist eine Nierenerkrankung ursächlich beteiligt. Man spricht hier von renaler Hypertonie. Ein renaler Hypertonus kann vaskulär bedingt sein (d.h. infolge einer Nierenarterienerkrankung (s. Tabelle 35.1)), er kann auf eine renale Nierenparenchymerkrankung zurückzuführen sein (Tabelle 35.2), oder er kann die Folge einer Kombination aus beiden sein. Viele Fälle einer renalen Hypertension sind reversibel, wenn sie richtig diagnostiziert und behandelt werden.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ayers CR, Harris RH, Lefer LG: Control of renin release in experimental hypertension. Circ Res 1969; 24/25 (Suppl 1):103Google Scholar
  2. Blake WD et al: Effect of renal arterial constriction on excretion of sodium and water. Am J Physiol 1950; 163:422PubMedGoogle Scholar
  3. Brenner BM, Stenin JH (editors): Hypertension. Vol 8 of: Contemporary Issues in Nephrology. Churchill Livingstone, 1981Google Scholar
  4. Brunner HR et al: Angiotensin II blockade in man by sarlala8-angiotensin II for understanding and treatment of high blood pressure. Lancet 1973; 2:1045PubMedCrossRefGoogle Scholar
  5. Brunner HR et al: Essential hypertension: Renin and aldosterone, heart attack, and stroke. N Engl J Med 1972; 286:441PubMedCrossRefGoogle Scholar
  6. Brunner HR et al: Hypertension of renal origin: Evidence for two different mechanisms. Science 1971; 174:1344PubMedCrossRefGoogle Scholar
  7. Case DB, Atlas SA, Laragh JH: Physiologic effects and blockade. Pages 541–550 in: Frontiers in Hypertension Research. Laragh JH, Buhler FR, Seidin DW (editors). Springer-Verlag, 1982Google Scholar
  8. Case DB, Atlas SA, Laragh JH: Reactive hyperreninemia to angiotensin blockade-identified renovascular hypertension. Clin Sci 1979; 57 (Suppl 5):313SGoogle Scholar
  9. Case DB et al: Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med 1977; 296:641PubMedCrossRefGoogle Scholar
  10. Eyler WR et al: Angiography of the renal areas, including a comparative study of renal arterial stenosis in patients with and without hypertension. Radiology 1962; 78:879PubMedGoogle Scholar
  11. Forster JH et al: Renovascular occlusive disease: Results of operative treatment. JAMA 1975; 231:1043CrossRefGoogle Scholar
  12. Goldblatt H, Lynch J, Hangel R: Studies on experimental hypertension. J Exp Med 1934; 59:347PubMedCrossRefGoogle Scholar
  13. Harvey RJ et al: Screening for renovascular hypertension. JAMA 1985; 254:388CrossRefGoogle Scholar
  14. Holley KE et al: Renal artery stenosis: A clinical-pathologic study in normotensive patients. Am J Med 1964; 37:14PubMedCrossRefGoogle Scholar
  15. Howard JE et al: Hypertension resulting from unilateral renovascular disease and its relief by nephrectomy. Bull Johns Hopkins Hosp 1954; 94:51PubMedGoogle Scholar
  16. Hunt JC et al: Renal and renovascular hypertension: A reasoned approach to diagnosis and management. Arch Intern Med 1975; 133:988CrossRefGoogle Scholar
  17. Judson WE, Helmer OM: Diagnostic and prognostic value of renin activity in renal venous plasma in renovascular hypertension. Hypertension 1965; 13:79Google Scholar
  18. Kaufman JJ: Renovascular hypertension: The UCLA experience. J Urol 1979; 121:139PubMedGoogle Scholar
  19. Laragh JH (editor): Hypertension Manual. York Medical Books, 1973Google Scholar
  20. Liard JF et al: Renin, aldosterone, body fluid volumes, and the baroreceptor reflex in the development and reversal of Goldblatt hypertension in conscious dogs. Circ Res 1974; 34:549PubMedGoogle Scholar
  21. Libertino JA et al: Renal artery revascularization: Restoration of renal function. JAMA 1980; 244:1340PubMedCrossRefGoogle Scholar
  22. Lyons DE et al: Captopril stimulation of differential renins in renovascular hypertension. Hypertension 1983; 5:615PubMedGoogle Scholar
  23. Marks LS, Maxwell MH: Renal vein renin value and limitations in the prediction of operative results. Urol Clin North Am 1975; 2:311PubMedGoogle Scholar
  24. Maxwell MH, Lupu AN: Excretory urogram in renal arterial hypertension. J Urol 1968; 100:395Google Scholar
  25. Maxwell MH, Lupu AN, Kaufman JJ: Individual kidney function tests in renal arterial hypertension. J Urol 1968; 100:384PubMedGoogle Scholar
  26. Maxwell MH, Lupu AN, Taplin GV: Radioisotpe renogram in renal arterial hypertension. J Urol 1968; 100:376PubMedGoogle Scholar
  27. Miller ED Jr, Samuels AI, Haber E: Inhibition of angiotensin conversion in experimental renovascular hypertension. Science 1972; 177:1108PubMedCrossRefGoogle Scholar
  28. Muller FB et al: The Captopril test for identifying renovascular disease in hypertensive patients. Am J Med 1986; 80:633PubMedCrossRefGoogle Scholar
  29. Nicholson JP et al: Cigarette smoking in renovascular hypertension. Lancet 1983; 2:765PubMedCrossRefGoogle Scholar
  30. Novick AC et al: Diminished operative morbidity and mortality following revascularization for atherosclerotic renovascular disease. JAMA 1981; 246:749PubMedCrossRefGoogle Scholar
  31. Osborne RW et al: Digital video subtraction angiography: Screening technique for renovascular hypertension. Surgery 1981; 90:932PubMedGoogle Scholar
  32. Pickering TG et al: Predictive value and changes of renin secretion in hypertensive patients with unilateral renovascular disease undergoing successful renal angioplasty. Am J Med 1984; 76:398PubMedCrossRefGoogle Scholar
  33. Sealey JE et al: The physiology of renin secretion in essential hypertension: Estimation of renin secretion rate and renal plasma flow from peripheral and renal vein renin levels. Am J Med 1973; 55:391PubMedCrossRefGoogle Scholar
  34. Simon N et al: Clinical characteristics of renovascular hypertension. JAMA 1972; 220:1209PubMedCrossRefGoogle Scholar
  35. Sos TA et al: Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309:274PubMedCrossRefGoogle Scholar
  36. Stockigt JR et al: Renal-vein renin in various forms of renal hypertension. Lancet 1972; 1:1194PubMedCrossRefGoogle Scholar
  37. Thibonnier M et al: Improved diagnosis of unilateral renal artery lesions after Captopril administration. JAMA 1984; 25:56CrossRefGoogle Scholar
  38. Vaughan ED Jr: Laboratory tests in the evaluation of renal hypertension. Urol Clin North Am 1979; 6:485PubMedGoogle Scholar
  39. Vaughan ED Jr et al: Clinical evaluation of renovascular hypertension and therapeutic decisions. Urol Clin North Am 1984; 11:393PubMedGoogle Scholar
  40. Vaughan ED Jr et al: Hypertension and unilateral parenchymal renal disease: Evidence for abnormal vasoconstriction-volume interaction. JAMA 1975; 233:1177PubMedCrossRefGoogle Scholar
  41. Vaughan ED Jr et al: Renovascular hypertension: Renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability. Am J Med 1973; 55:402PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • R. E. Sosa
  • E. D. VaughanJr.

There are no affiliations available

Personalised recommendations